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The link between integrin activity regulation and cellular mechanosensing of tissue rigidity, especially
on different extracellular matrix ligands, remains poorly understood. Here, we find that primary
mouse mammary gland stromal fibroblasts (MSFs) are able to spread efficiently, generate high forces,
and display nuclear YAP on soft collagen-coated substrates, resembling the soft mammary gland tis-
sue. We describe that loss of the integrin inhibitor, SHARPIN, impedes MSF spreading specifically on
soft type I collagen but not on fibronectin. Through quantitative experiments and computational
modeling, we find that SHARPIN-deficient MSFs display faster force-induced unbinding of adhesions
from collagen-coated beads. Faster unbinding, in turn, impairs force transmission in these cells, partic-
ularly, at the stiffness optimum observed for wild-type cells. Mechanistically, we link the impaired
mechanotransduction of SHARPIN-deficient cells on collagen to reduced levels of collagen-binding in-
tegrin a11b1. Thus integrin activity regulation and a11b1 play a role in collagen-specificmechanosens-
ing in MSFs.
INTRODUCTION
Fibroblasts exert high forces that are implicated in the morphogenetic rearrangement of extracellular
matrices (ECMs) (Harris et al., 1981). In the developing mammary gland, stromal cell-mediated organiza-
tion of the ECM regulates mammary ductal morphogenesis (Brownfield et al., 2013; Ingman et al., 2006).
Despite this important function, investigations into mammary stromal components are secondary to that
of the mammary epithelium. In addition to ECM organization in normal tissue, mammary gland stromal
fibroblasts (MSFs) play a central role in the pro-invasive stiffening of breast tumor stroma (Navab et al.,
2016), and therefore, understanding the mechanical aspects of these cells is of clinical interest. Although
the role of integrins as cell mechanosensors and transducers is well established, the link between the
regulation of integrin activity and the mechanosensing response on different ECM ligands remains poorly
understood. SHARPIN is a cytosolic adaptor protein that, among other functions, binds to the intracel-
lular integrin alpha tails and inhibits integrin activity in different cell types in vitro and in vivo (Kasirer-
Friede et al., 2019; Peuhu et al., 2017a, 2017b; Pouwels et al., 2013; Rantala et al., 2011). We have previ-
ously demonstrated that stromal SHARPIN deficiency interferes with normal mouse mammary gland
development and collagen fiber assembly in vivo (Peuhu et al., 2017a). However, how SHARPIN mediates
integrin-dependent mechanotransduction remains unresolved.
Collagen is abundant in the mammary gland stroma and plays a key role in regulating the physical and
biochemical properties of the mammary gland. Alignment of stromal collagen bundles is critical for normal
mammary gland development providing migration cues to the outgrowing duct during puberty (Brown-
field et al., 2013; Ingman et al., 2006). There are four collagen-binding integrin heterodimers in mammals:
the more ubiquitously expressed a1b1, a2b1, and a11b1 and the cartilage-specific a10b1 (Zeltz and Gull-
berg, 2016). Of these, the fibrillar collagen-binding integrins a2b1 and a11b1 have been strongly linked
to collagen remodeling and turnover (Abair et al., 2008; Ivaska et al., 1999; Popova et al., 2007; Riikonen
et al., 1995; Tiger et al., 2001) and a11b1 to the induction of cancer stromal stiffness (Navab et al., 2016;
Zeltz et al., 2019). Furthermore, ‘‘trail blazer’’ breast cancer cells with high invasive capacity are character-
ized by high integrin a11b1 expression (Westcott et al., 2015). Nevertheless, integrin a11b1 functions are
rather poorly understood, and the role of this receptor in regulating cell-collagen interactions in the mam-
mary gland has not been previously studied.iScience 23, 100907, March 27, 2020 ª 2020 The Author(s).
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In order to sense the properties of the surrounding ECM, cells use dynamic molecular bonds, often referred
to as molecular clutches, to exert forces within the cell boundary (Elosegui-Artola et al., 2018). A molecular
clutch can be defined as a dynamic link between the ECM, integrin adhesion receptors, intracellular
adaptor proteins, and the actomyosin cytoskeleton (Elosegui-Artola et al., 2014, 2016). By quantification
of the molecular clutch binding dynamics, and using mathematical modeling, one can predict the average
force transmission of cells to the ECM as a function of substrate stiffness (Elosegui-Artola et al., 2014, 2016).
Here, we have combined mathematical modeling with cell biology to investigate the biomechanical prop-
erties of primary mouse MSFs and to understand how the integrin inhibitor SHARPIN affects integrin-
dependent force generation and mechanotransduction. We find that, somewhat counterintuitively, in spite
of having higher integrin b1 activity SHARPIN-deficient MSFs were defective in spreading on soft hydrogels
with a stiffness similar to the mammary gland tissue in vivo. They also had faster force-induced cell-ECM
unbinding rates. Interestingly, both of these defects were specific to collagen and not observed on fibro-
nectin. The molecular clutch model predicted that increased clutch unbinding rates result in the loss of
stiffness-dependent traction maximum and increased actin flow rates at low rigidities. Importantly, these
predictions were recapitulated experimentally in SHARPIN-deficient primary MSFs on collagen I. SHAR-
PIN-deficient MSFs had significantly downregulated collagen-binding integrin a11b1 levels, explaining
mechanistically their unexpected inability to couple to collagen. These data highlight an important diver-
gence in the regulation of collagen I- and fibronectin-binding integrin heterodimers in the mammary gland
stroma with implications for the mechanical response of fibroblasts. Moreover, these insights are likely to
improve our understanding of fibrotic diseases including cancer where fibroblasts exhibit deregulated in-
tegrin activity (Erdogan et al., 2017; Glentis et al., 2017).RESULTS
Increased Integrin Activity Correlates with Reduced Spreading of Mouse Mammary Gland
Fibroblasts on Soft Collagen I, but Not on Soft Fibronectin, -Coated Matrices
Based on previous observations that primary MSFs from SHARPIN-deficient mice (chronic proliferative
dermatitis null mutation, cpdm; Sharpincpdm/cpdm; Sharpincpdm) (HogenEsch et al., 1993; Seymour et al.,
2007) have increased integrin b1 activity but, counterintuitively, impaired capacity to contract collagen
gels (Peuhu et al., 2017a), we sought to investigate the link between integrin activity and force transduction.
We first confirmed by flow cytometry the cell-surface levels of total and active integrin b1 with conforma-
tion-specific antibodies. As expected, Sharpincpdm MSFs expressed lower total integrin b1 cell-surface
levels but equal levels of active integrin b1 compared with SHARPIN-expressing (Sharpin+/+or
Sharpincpdm/+; from here on referred to as wild-type) cells, indicating that in SharpincpdmMSFs a higher pro-
portion of integrin b1 is in the active conformation on the cell surface (Figures 1A and S1A), in line with our
previous studies with MSFs (Peuhu et al., 2017a) and other cell types (Peuhu et al., 2017b; Rantala et al.,
2011). Next, we studied the ability of wild-type and Sharpincpdm MSFs to spread in response to ECM stiff-
ness and ligand type. MSFs were seeded at equal density on soft (2 kPa) fibronectin or collagen I (a satu-
rating concentration of 20 mg/mL of each ligand was used, Figure S1B) pre-coated polyacrylamide gels,
approximating the stiffness of the mammary tissue in vivo (Lopez et al., 2011; Peuhu et al., 2017a; Plodinec
et al., 2012). As expected based on the higher integrin b1 activity and faster focal adhesion (FA) turnover
compared with wild-type MSFs (Peuhu et al., 2017a; Rantala et al., 2011), Sharpincpdm MSFs spread more
compared with wild-type MSFs when seeded on fibronectin-coated hydrogels (Figures 1B and1C). In
contrast, on 2 kPa collagen-I-coated hydrogels Sharpincpdm MSFs were less spread than wild-type MSFs
(Figures 1B and1C). When cell spreading area was measured on a stiffness range from 0.8 to 13 kPa (Fig-
ure 1C), on collagen-I-coated hydrogels, wild-typeMSFs displayed a spreading optimum on 2 kPa, whereas
Sharpincpdm MSFs were significantly smaller and only fully spread at 13 kPa (Figure 1C). These data present
an unexpected conundrum; at lower stiffness [corresponding to the higher end of the rigidity spectrum re-
ported for mammary gland tissue in vivo, 0.1–2 kPa (Peuhu et al., 2017a; Plodinec et al., 2012)], loss of SHAR-
PIN (coinciding with increased integrin b1 activity) correlates with defective MSF spreading on collagen I,
whereas on fibronectin the opposite is observed.
Given that Sharpincpdm MSFs have faster FA dynamics (increased assembly and disassembly rates) on
collagen-coated rigid glass substrate (Peuhu et al., 2017a), we next evaluated the effect of SHARPIN
deficiency on FA maturation (number and average length) on a range of hydrogel rigidities. Vinculin, a me-
chanosensitive adaptor molecule recruited to mature FA (Chen et al., 2006; del Rio et al., 2009), was immu-







































































































































Figure 1. Increased Integrin Activity Correlates with Reduced Spreading of MSFs on Soft Collagen I
(A) Quantification of relative integrin b1 activity [active (clone, 9EG7)/total (clone, HMb1-1)] cell-surface levels (n = 7 independent experiments) in
Sharpincpdm compared with wild-type MSFs by flow cytometry.
(B) Representative images of wild-type and Sharpincpdm MSFs plated for 3–4 h on 2 kPa fibronectin (upper panel) or collagen I (lower panel)-coated
polyacrylamide (PAA) hydrogels and labeled for F-actin (white) and nuclei (blue). Cell edges are outlined with yellow dashed lines.
(C) Quantification of cell spreading in wild-type compared with Sharpincpdm MSFs on 0.8, 2, 4, and 13 kPa PAA hydrogels coated with fibronectin (upper
panel) or collagen I (lower panel) based on immunofluorescence. Data are pooled from three independent experiments, nwt= 90, 95, 103, 88 and
nSharpincpdm= 72, 80, 93, 88 cells (fibronectin, from left to right) and nwt= 64, 105, 91, 109 and nSharpincpdm= 59, 118, 97, 77 cells (collagen I, from left to right).
(D) Representative output images of FA analysis for individual cells plated on 2 kPa collagen-I-coated PAA hydrogels (FA, red; cell borders, black).
(E and F) Quantification of the number of FA per cell (E) and the length of FA (F) in wild-type compared with Sharpincpdm MSFs plated on collagen-I-coated
0.8, 2, 4, and 13 kPa PAA hydrogels. Data are pooled from three independent experiments, nwt= 64, 94, 73, 83, nSharpincpdm= 59, 97, 73, 56 cells (# Adhesion
per cell, from left to right), and nwt= 41, 94, 73, 109 and nSharpincpdm= 42, 98, 74, 73 cells (Adhesion length, from left to right).
Mean G SEM in all graphs. Mann–Whitney U-test; red lines below p values indicate the data points compared. Scale bars: 20 mm. See also Figure S1.1D and S1C). Wild-type and Sharpincpdm MSFs (Figure 1D) demonstrated similar FA number and length on
collagen-I-coated hydrogels (Figures 1E and 1F). Interestingly, both wild-type and Sharpincpdm primary
MSFs formed mature, vinculin-containing adhesions on soft matrices reaching the maturation maxima
already on 2–4 kPa (Figure 1F). On fibronectin, Sharpincpdm MSFs demonstrated either longer or more
FA on 2–4 kPa hydrogels (Figures S1D–S1F), consistent with increased cell spreading (Figures 1B
and1C). Furthermore, MSFs exhibited nuclear localization of the mechanosensitive transcription factor
Yes-associated protein (YAP) at 2 kPa stiffness (Figure S1G). This localization was reduced in Sharpincpdm
MSFs (Figure S1G, H). The nuclear localization of YAP and the ability of MSFs to generate elongated,
stress-fiber-linked adhesions on a low stiffness are counter to the stiffness-induced adhesion reinforce-
ment/maturation and nuclear YAP translocation detected in other cell types (Elosegui-Artola et al.,
2016), possibly mirroring the adaption of these primary cells to their soft growth environment in the mam-
mary gland (Lopez et al., 2011; Peuhu et al., 2017a; Plodinec et al., 2012). In conclusion, Sharpincpdm MSFs
demonstrate reduced capacity to spread on soft collagen I-coated matrices, whereas the opposite occurs
on fibronectin-coated substratum.
Increased Integrin Activity Correlates with Faster Integrin-Collagen Binding Dynamics in
MSFs
We then assessed how the altered integrin activity in Sharpincpdm MSFs affects the binding and unbinding
properties of the cells to matrix ligands (Figure 2A). For this we employed ECM-coated bead recruitment
and detachment experiments. Previous studies indicate that adhesions formed by cells on beads of com-
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Figure 2. SHARPIN-Deficient MSFs Show Faster Integrin-Collagen Binding Dynamics
(A) Schematic representation of the set up for integrin recruitment (left panel) and magnetic tweezer (right panel)
experiments.
(B) Quantification of integrin b1 recruitment to collagen I (left panel) or fibronectin (right panel)-coated silica beads; nwt =
62 and nSharpincpdm = 51 cells (collagen I) and nwt = 33 and nSharpincpdm = 24 cells (fibronectin) from two independent
experiments.
(C) Quantification of detachment time of wild-type and Sharpincpdm MSFs from collagen I (left panel) or fibronectin (right
panel)-coated magnetic beads; nwt and nSharpincpdm = 34 cells (collagen) and nwt = 29 and nSharpincpdm = 37 cells
(fibronectin) from two independent experiments. Mean G SEM in all graphs. Unpaired t test. Col I, collagen I; FN,
fibronectin.[30 min vs. 20-35 min; (González-Tarragó et al., 2017; Jones et al., 2015)] and recruit the same core-adhe-
some proteins as the adhesions that form on the basal side of adherent cells (Guilluy et al., 2011; Jones
et al., 2015). Sharpincpdm MSFs displayed slightly increased recruitment of integrin b1 to collagen-I-coated
silica beads when compared with wild-type cells, whereas no significant differences in binding to fibro-
nectin-coated beads were observed (Figure 2B). We then employed a magnetic tweezers setup (Elose-
gui-Artola et al., 2014), a method that allows quantitative measurement of the strength of receptor-ligand
bonds, to apply force to collagen I or fibronectin-coated beads attached to cells, and evaluated the time
required to detach beads from cells (Figure 2A). Detachment times of collagen-coated beads were signif-
icantly lower for Sharpincpdm MSFs compared with wild-type cells (Figure 2C). However, no significant dif-
ferences were observed with fibronectin-coated beads (Figure 2C). The significant decrease in bead
detachment time under force suggests that unbinding rates under force are increased. Thus, overall the
results are consistent with an effect of SHARPIN deficiency in increasing both binding and unbinding rates
of integrins to collagen, thereby maintaining the overall recruitment constant.
Molecular Clutch Model Predicts the Absence of Traction Peak in Sharpincpdm Cells at
Biologically Relevant Rigidities
The ability of cells to sense and respond to rigidity, and apply force to the matrix, is regulated by the
different components of the adhesive and contractile molecular machinery that functions jointly as a
cellular molecular clutch (Case and Waterman, 2015; Chan and Odde, 2008; Elosegui-Artola et al., 2014).
Clutch dynamics are a function of several parameters: the number and binding dynamics of integrin-
ECM bonds, reinforcement of the integrin-actin link through talin unfolding and vinculin recruitment, acto-
myosin contractility, and substrate compliance. Unlike previously studied cell types (Elosegui-Artola et al.,
2016), theMSFs are able to generate fully mature adhesions at low stiffness. This suggests that MSFs should
exhibit the fundamental prediction of the molecular clutch, a biphasic force/rigidity relationship, which is4 iScience 23, 100907, March 27, 2020
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Figure 3. Molecular Clutch Model Predicts the Absence of Traction Peak in SHARPIN-Deficient Cells at
Biologically Relevant Rigidities
(A) Quantification of relative pMLC2 expression levels in wild-type compared with SharpincpdmMSFs plated on collagen-I-
coated PAA hydrogels with the indicated stiffness; n = 3 independent experiments.
(B) Prediction of the traction forces generated by wild-type and Sharpincpdm MSFs on collagen-I-coated PAA hydrogels
based on the molecular clutch model. The stiffness range covered in (C) is highlighted.
(C) Average forces exerted by wild-type compared with Sharpincpdm MSFs on collagen-I-coated PAA hydrogels with the
indicated stiffness measured by traction force microscopy, nwt = 20, 20, 21, 20, 19 and nSharpincpdm = 18, 25, 21, 18, 17 cells
(from left to right) from two independent experiments.
(D) Average forces exerted by wild-type compared with Sharpincpdm MSFs on fibronectin-coated PAA hydrogels with the
indicated stiffness measured by traction force microscopy, nwt= 11, 11, 23, 14, 10 and nSharpincpdm= 10, 13, 23, 11, 10 cells
(from left to right) from two independent experiments.
(E) Representative images of Lifeact-GFP-transfected wild-type and Sharpincpdm MSFs plated on 2 kPa collagen-I-coated
PAA hydrogels. Insets are kymographs showing actin retrograde flow along the red line (time = 125s, imaged every
second). The slope of the line was used to calculate the actin retrograde flow rate.
(F) Quantification of actin retrograde flow in wild-type compared with SharpincpdmMSFs, nwt = 10 and nSharpincpdm = 8 cells
(1 measurement/cell), from three independent experiments.
MeanG SEM in all graphs. Mann–Whitney U-test, red lines below p values indicate the data points compared. Scale bars:
10 mm. See also Figure S2 and Table S1.almost always masked by the fact that adhesion growth and reinforcement normally occur only at high ri-
gidities (Chan andOdde, 2008; Elosegui-Artola et al., 2016). This exciting scenario prompted us tomeasure
the remaining necessary parameters required for computational modeling of the molecular clutch in these
cells. Actomyosin contractility is an important component of the molecular clutch and is regulated by phos-
phorylation of myosin light chain 2 (pMLC2). In talin 1/ knockout mouse embryonic fibroblasts (MEFs)
(talin 1/ MEFs), which display a wild-type phenotype due to compensatory upregulation of endogenous
talin 2 and have previously been studied with comparable methods (Elosegui-Artola et al., 2016), pMLC2
levels are largely independent of substrate stiffness (Elosegui-Artola et al., 2016). We compared our
MSFs with the talin 1/ MEFs and observed increasing pMLC2 levels in MSFs in response to increasing
stiffness (Figures 3A, S2A, and S2B), similar to the previously observed response of vascular smooth muscle
cells (Polte et al., 2004). Furthermore, higher pMLC was observed in MSFs plated on soft substrate as
compared with talin 1 / MEFs (Elosegui-Artola et al., 2016) (Figure S2A). However, no significant differ-
ences in pMLC2 were detected between wild-type and Sharpincpdm MSFs, suggesting that myosin activity
remains predominantly unaffected in the absence of SHARPIN.
Taking into consideration these experimentally determinedMSF features, we employed the computational
model of the molecular clutch (Elosegui-Artola et al., 2014, 2016). It predicts that in the absence of changes
in integrin recruitment or adhesion growth as a function of stiffness, the cells should display a biphasic
force/rigidity response, even if myosin contractility increases with rigidity (Figure 3B). The other prediction
arising from our modeling is that increased integrin binding and unbinding rates, as observed in Shar-
pincpdm MSFs, should displace the traction force peak to higher rigidities. To test the model predictions,
we measured cell-matrix force transmission using traction force microscopy. As predicted, wild-type cells
on collagen I displayed a biphasic response of force as a function of stiffness, on the lower stiffness range,
with a force maximum at 2 kPa (Figure 3C andS2C). Thus, MSFs represent the first mammalian primary celliScience 23, 100907, March 27, 2020 5
type that shows this predicted biphasic force response without genetic perturbation. In Sharpincpdm cells,
the concomitant increase in binding and unbinding rates should shift the force curve, displacing the force
peak to higher rigidities. Accordingly, the maximum force peak at 2 kPa was absent (Figures 3C and S2C),
closely replicating the result of the molecular clutch modeling (Figure 3B). In this case, no force peak was
observed, potentially because it was displaced to a stiffness above the range where traction forces were
measured experimentally. Of note, wild-type cells exhibit a stiffness-dependent additional increase in
force transmission above 4 kPa that is not predicted by the model indicating that the modeling corre-
sponds to the experimental data only in the lower stiffness range. The nature of this regime remains un-
known and warrants further investigation.
Finally, the molecular clutch model also predicts that changes in force should inversely correlate with actin
flow. As predicted, actin flow of actively spreading (plated for 45–105 min) Sharpincpdm cells (average
51 nm/s) on 2 kPa collagen-I-coated hydrogels was also elevated with respect to wild-type cells (average
35 nm/s) (Figures 3E and3F). Because of the limited transfection efficiency in the primary MSFs and the
need to isolate them freshly from mouse mammary gland, this single stiffness was selected based on
the highest differences in traction force measurements. Interestingly, in stably adhered MSFs (plated for
4 h) on 2 kPa collagen-I-coated hydrogels, very slow actin retrograde flow was observed compared to talin
1/ MEFs (Figure S2D), and measurement of actin flow in MSFs was beyond the detection limit. This is in
stark contrast to the rapid actin flow detected in other cell types on soft substrate (Bangasser et al., 2017;
Chan and Odde, 2008; Elosegui-Artola et al., 2016), further demonstrating the adaption of MSFs to a soft
environment. This may be attributed, in part, to integrin expression. We compared the cell-surface levels of
several integrin subunits in talin 1/MEFs and wild-typeMSFs and observed that MSFs express nearly two
times more integrin b1 and markedly more integrin a1-and a11-subunits compared to talin 1/MEFs (Fig-
ure S2E) that spread poorly on soft collagen (Figure S2F).
Consistent with the fact that no differences in adhesion behavior under force were observed with fibronectin-
coated beads (Figure 2C), wild-type and Sharpincpdm cells exerted the same forces on fibronectin-coated sub-
strates irrespective of stiffness and the cells displayed monotonic increase in force with increasing rigidity (Fig-
ure 3D). In contrast to collagen I substrate, MSFs did not show a force maximum at low rigidities on fibronectin.
As in Sharpincpdm cells on collagen, this lack of a biphasic force response could result from the limited stiffness
range used in these experiments (0.6–14.5 kPa) and suggests that the force maximum for MSF on fibronectin is
exerted at a stiffness above 14.5 kPa. Our observations support the view that different integrin heterodimers
form integrin-ligand bonds with different strengths depending also on ECM composition, which leads to varia-
tions in the force maximum on different ECM ligands.
Together, these data demonstrate that SHARPIN deficiency, and the consequent increase in integrin-
collagen unbinding rate, lead to significant effects in mechanotransduction in MSFs, providing a possible
explanation to our previous finding that Sharpincpdm MSFs are unable to remodel collagen in vitro and are
defective in supporting generation of mammary gland stromal architecture supportive of normal develop-
ment and ductal outgrowth (Peuhu et al., 2017a).Integrin a11b1 Protein Levels Regulate the Spreading of MSFs on Soft Matrices
Next, we asked how loss of SHARPIN could affect integrin binding dynamics and what the consequent effects
are. One potential explanation is that Sharpincpdm and wild-type MSFs exhibit differences in collagen-binding
integrin expression, leading to different ECM binding properties. An RNA sequencing dataset of wild-type
andSharpincpdmMSFs (Peuhuet al., 2017a)wasanalyzed for all thematrix-binding integrin subtypes (Figure S3A).
Of the collagen-binding integrin alpha subunits (Itga1, Itga2, Itga10, Itga11), which all form a heterodimer with
the integrin b1 subunit, Itga11 was the predominant a-subunit expressed at mRNA level, Itga1 was detected at
low levels and Itga10 or Itga2 were not detected. Importantly, no significant differences in integrin mRNA
expression levels were observed between wild-type and Sharpincpdm MSFs (Figure S3A).
Next we analyzed the cell-surface levels of the expressed collagen binding integrin a subunits. Sharpincpdm
MSFs had significantly reduced levels of integrins a1 and a11 compared with wild-type MSFs (Figure 4A).
Western blotting and immunofluorescence labeling further confirmed that integrin a11 levels were lower in
Sharpincpdm MSFs (Figures 4B–4D; mouse integrin a1 protein levels were not analyzed with western blot-
ting or immunofluorescence labeling due to the lack of suitable antibodies). In addition, siRNA-mediated
downregulation of SHARPIN reduced integrin a11 protein levels compared with control silencing (Figures6 iScience 23, 100907, March 27, 2020
4E and 4F). These data suggest that integrin a11 is acutely regulated by SHARPIN, and the low integrin a11
levels are not triggered by an in vivo compensatory effect in the Sharpincpdm animals. A reduced protein
level of integrin a11 was observed also in Sharpincpdm MSFs that were seeded on 2 kPa collagen-I-coated
hydrogels directly after isolation from the mouse mammary gland (Figure S3B), indicating that the
observed difference in integrin a11 is not induced by in vitro culture on stiff fibronectin-rich substratum
(plastic in the presence of serum fibronectin) and is prominent under conditions when collagen I is the
only provided ligand (Figure S3C).
As inactive and active integrins are trafficked and degraded differently (Arjonen et al., 2012; Rainero et al.,
2015), we speculated that the increased relative activity of integrin b1 could lead to increased targeting of
integrin a11b1 to lysosomal degradation in Sharpincpdm MSFs. This hypothesis was supported by the fact
that SHARPIN-deficient MSFs displayed more integrin a11 co-localization with Lamp1 (lysosomal marker)
than wild-type MSFs (Figures 4G and 4H). Furthermore, we observed accumulation of integrin a11 to the
Lamp1-positive compartment whenMSFs were treated with the lysosomal degradation disruptor Bafilomy-
cin A1 (Figures 4G and 4H). These data suggest that a subset of integrin a11 traffics to lysosomal degrada-
tion in MSFs and that this is enhanced in SHARPIN-deficient cells.
To investigate whether the reduced surface expression of integrin a1 and a11 in SharpincpdmMSFs could be
responsible for the impaired capability to spread on a compliant collagen-I-coated surface, we analyzed
cell spreading following siRNA-mediated downregulation of integrin a1 or integrin a11 (Figure 5A),
confirmed by qPCR (Figure S3D). In wild-type MSFs downregulation of integrin a11, but not integrin a1,
led to significantly reduced cell spreading on 2 kPa collagen-I-coated hydrogels that resembled the pheno-
type of SharpincpdmMSFs (Figure 1B). In contrast, no significant differences in cell area were observed when
the endogenously lower integrin a1 and integrin a11 levels were silenced in Sharpincpdm MSFs (Figure 5A).
These data indicate that appropriate levels of integrin a11, but not integrin a1, are important for regulating
the spreading of MSFs on soft collagen-I-coated substrates. This could be linked to the fact that integrin
a11 mediates strong binding to and contraction of fibrillar collagen I (Tiger et al., 2001), whereas integrin
a1 prefers non-fibrillar collagen IV and has lower binding affinity to fibrillar collagens (types I, II, and III)
(Tulla et al., 2001). However, this remains to be investigated.
To verify that integrin a11 levels are critical for collagen I interaction of MSFs, we performed rescue exper-
iments with ectopically expressed EGFP-tagged human integrin a11. Reintroduction of integrin a11 in
Sharpincpdm MSFs on collagen-I-coated 2 kPa hydrogels reversed their defective spreading (Figures 5B
and 5C). In contrast, overexpression of integrin a11-EGFP in wild-type MSFs modestly, albeit, non-signif-
icantly decreased cell spreading (Figures 5B and 5C). In addition, reintroduction of integrin a11 by ectopic
expression partially rescued the ligand detachment time in Sharpincpdm MSFs (Figure 5D). Taken together,
these results demonstrate that integrin a11b1 is essential in the integrin-collagen I binding dynamics and
spreading of MSFs on soft collagen-I-coated substrates and that the impaired mechanotransduction of
SHARPIN-deficient MSFs is coupled to reduced integrin a11b1 protein expression level.DISCUSSION
Here we have investigated the mechanotransduction of mammary gland stromal fibroblasts to gain insight
into the biologically essential role of these cells in sculpting themammary gland stromal architecture in vivo
(Peuhu et al., 2017a). Taking this experimentally challenging primary cell model (compared with the immor-
talized cell lines studied previously) has provided two interesting and unexpected observations related to
tissue-specific characteristics of mechanotransduction. First, our data comparing wild-type and SHARPIN-
deficient cells provide a striking example of how, even if major mechanical regulators such as myosin
contractility are not affected, merely changing integrin properties under force can dramatically affect
the cell’s mechanoresponse. Second, the fact that wild-type MSFs exhibit mature, vinculin-associated FA
irrespective of matrix stiffness allowed us to decouple traction force generation from adhesion maturation,
leading to the fundamental clutch model prediction of a biphasic traction-stiffness relationship that is
otherwise very elusive to observe (Elosegui-Artola et al., 2018).
The differential regulation of collagen- and fibronectin-binding integrins and the mechanobiological implica-
tions of these differences remain poorly understood. Here, we have investigated the consequences of SHARPIN
deficiency on cell mechanosensing, integrin ligand-binding dynamics, and traction force generation and con-
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Figure 4. SHARPIN Regulates Integrin a11b1 Protein Levels
(A) Analysis of cell-surface expression (median fluorescence) of integrin a1 and a11 in Sharpincpdm relative to wild-type
MSFs, nItga1 =6 and nItga11 = 8 from six independent flow cytometry experiments.
(B and C) (B) Representative Western blot analysis of integrin a11 protein expression in wild-type and Sharpincpdm MSFs
and (C) quantification of the relative integrin a11 expression levels, nwt and nSharpincpdm = 7 from five independent
experiments. GAPDH was detected for loading control.
(D) Representative images of immunolabelled integrin a11 (green) and total integrin b1 (magenta) in wild-type and
Sharpincpdm MSFs plated on 2 kPa collagen-I-coated PAA hydrogels. Nuclei (blue) were co-labeled.
(E and F) (E) Representative Western blot analysis of integrin a11 and SHARPIN protein expression in wild-type MSFs
silenced with control or SHARPIN-targeting siRNA and (F) quantification of the relative integrin a11 expression levels; n =
5 independent experiments. GAPDH was detected for loading control.
(G) Representative images of immunolabelled integrin a11 (green) and the lysosomal marker Lamp1 (magenta) in control-
treated (ctrl) or Bafilomycin A1-treated (100 nM, 6h) wild-type and Sharpincpdm MSFs plated on collagen. Region of
interest (yellow) shows examples of co-localization (white spots, highlighted with red arrow).
(H) Quantification of relative (to wt control) co-localization of integrin a11 and Lamp1 in control-treated or Bafilomycin-A1-
treated wild-type and SharpincpdmMSFs plated on collagen; n = 76, 102, 89, 125 cells (from left to right) pooled from three
independent experiments; line under p value indicates which samples are compared with each other.
Mean G SEM in all graphs. (A) Wilcoxon matched-pairs signed rank test. (C, F, and H) Mann-Whitney U-test. Scale bars:
20 mm. See also Figure S3.activity regulator SHARPIN, the protein levels of the collagen-binding integrin a11b1 are downregulated. This is
likely to be the main reason for the significantly increased unbinding of SHARPIN-deficient MSFs from collagen-
coated beads under force. As the remaining integrin a11b1 is more likely to be in the primed active conforma-
tion, due to the increase in relative integrin b1 activity, this could account for the small increase of integrin recruit-
























































































Figure 5. Integrin a11b1 Regulates the Spreading of MSFs on Soft Matrices
(A) Quantification of the cell area in wild-type and Sharpincpdm MSFs silenced with control, integrin a1, or integrin a11
targeting siRNA and plated on 2 kPa collagen-I-coated PAA hydrogels; n = 94, 91, 93, 82, 88, 90 cells (from left to right)
from three independent experiments.
(B) Representative images of integrin a11-EGFP-transfected wild-type and Sharpincpdm MSFs plated on 2 kPa collagen-I-
coated PAA hydrogels and co-labeled for F-actin (magenta) and nuclei (blue).
(C) Quantification of cell area in non-transfected and integrin a11-EGFP-transfected wild-type and Sharpincpdm MSFs
plated on 2 kPa collagen-I-coated PAA hydrogels. Data are pooled from two independent experiments; n = 37, 31, 46, 48
cells (from left to right).
(D) Quantification of detachment time of wild-type, Sharpincpdm, and integrin a11-EGFP-transfected Sharpincpdm MSFs
from collagen-I-coated magnetic beads. Data are pooled from three independent experiments; n = 91, 101, 46 cells (from
left to right).
MeanG SEM in all graphs. (A) Unpaired t test. (C and D) Mann-WhitneyU-test. Line under p value indicates which samples
are compared with each other. Scale bars: 20 mm. See also Figure S3.adhesion turnover of SHARPIN-deficientMSFs (Peuhuet al., 2017a). Importantly, themolecular clutchmodel was
able to predict the absence of traction peak and increased actin flow rate at low rigidities based on increased
clutch binding and unbinding rates to collagen, measured by magnetic tweezers in SHARPIN-deficient cells. Of
note, whereas the response to force of integrin-collagen bonds is not known, our model assumed a catch bond
behavior. This should, however, not affect our conclusions, because the key aspects of the molecular clutch
model found here (biphasic behavior, plus the role of fold changes in binding and unbinding rates) are general
to both catch and slip bonds (Bangasser et al., 2013).
Our model failed, however, to predict the final increase in force transmission in wild-type cells with increasing
stiffness. Although the details of this regime warrants further investigation, we note that in conditions with very
lowactin flowrates,matureadhesions, andvery stableactin fibers, cytoskeletal reorganizationeventsother than
fast actin flowcouldbedeterminant of the cellular force transmission (Oakes et al., 2012). In all, we acknowledge
that the model prediction corresponds to the experimental data only in the soft stiffness range, possibly
because not all cellular parameters have been, and can be, taken into account by the molecular clutch model.
Although SHARPIN regulates the activity of both collagen- and fibronectin-binding integrins (Rantala et al.,
2011), the low levels of fibrillar collagen-binding integrin a11 in SHARPIN-deficient MSFs results in differentiScience 23, 100907, March 27, 2020 9
mechanosensitive responses of these cells on collagen and fibronectin. This is in line with the established
role of integrin a11b1 (Lehnert et al., 1999), in the regulation of collagen contractility (Popova et al., 2007;
Tiger et al., 2001) and in collagen-linked disease conditions, such as fibrosis, cancer invasion, and particu-
larly in cancer-associated fibroblasts (Bansal et al., 2017; Navab et al., 2016). The regulatory pathways
modulating the activity of collagen-binding integrins may be distinct from other integrin heterodimers.
The vast majority of studies investigating integrin activation are based on the platelet-specific integrin
aIIbb3 and the fibronectin receptors integrin a5b1 and avb3, which are primarily regulated by inside-out
and outside-in signaling. In turn, only a few studies have addressed activity regulation in the context of
collagen-binding integrins. Heterodimerization of a1b1 and a2b1 integrins has been postulated to have
a key role in their activity regulation based on the lower affinity of integrin a1 and a2 to integrin b1 (Lu
et al., 2016). Thus, regulation of the expression levels of collagen-binding integrins may be particularly
important for their ligand-binding dynamics.
SHARPIN is a multifunctional adapter protein that has been implicated in a number of other signaling path-
ways, including inhibition of integrin activity (Kasirer-Friede et al., 2019; Peuhu et al., 2017a, 2017b; Pouwels
et al., 2013; Rantala et al., 2011). SHARPIN promotes canonical Nuclear factor (NF)-kB activation (Gerlach
et al., 2011; Tokunaga et al., 2009) and other inflammatory signaling cascades as part of the linear ubiquitin
assembly complex (LUBAC) (Chattopadhyay et al., 2016; Dubois et al., 2014; Rodgers et al., 2014; Zak et al.,
2011). Furthermore, SHARPIN regulates the functions of the Arp2/3 protein complex (Khan et al., 2017),
T cell receptor (Park et al., 2016), and caspase 1 (Nastase et al., 2016) in an LUBAC-independent manner
and interacts with PTEN (He et al., 2010), SHANK proteins (Lim et al., 2001), and EYA transcription factors
(Landgraf et al., 2010). In this study, reduced integrin a11 protein levels were directly linked to mechano-
biological phenotypes in SHARPIN-deficient MSFs, whereas integrin expression at the transcriptional level
remained comparable to wild-type MSFs. Because NF-kB is a transcription factor that functions predom-
inantly through regulation of gene expression, our data imply that NF-kB might not be the primary mech-
anism involved in the regulation of integrin a11 in SHARPIN-deficient MSFs. Currently, we lack the detailed
mechanisms accounting for the reduced integrin a11 protein levels in SHARPIN-deficient MSFs and in wild-
typeMSFs upon SHARPIN silencing. However, it is likely that increased lysosomal trafficking of integrin a11,
in the absence of SHARPIN, is contributing to elevated integrin degradation in these cells. This would be in
line with previous studies linking integrin activation to reduced receptor recycling rates and increased lyso-
somal degradation (De Franceschi et al., 2015).
Together, our findings demonstrate how altered integrin activity in SHARPIN-deficient primary MSFs corre-
lates with deregulated cell spreading and traction force generation in response to substrate ligand compo-
sition and stiffness. The central role for integrin a11, uncovered here, in regulating mechanotransduction on
collagen may also be essential to the pathological behavior of fibroblasts in cancerous or fibrotic tissues. As
both SHARPIN and integrin a11b1 are significant regulators of cancer tumorigenesis and dissemination, as
well as fibroblast contractility and collagen remodeling (He et al., 2010; Navab et al., 2016; Peuhu et al.,
2017a; Tamiya et al., 2018; Zhu et al., 2007), increased understanding of their functional interplay is of wide
interest. Finally, our finding that the mechanical output of fibroblasts can be strongly influenced by a single
parameter of themolecular clutch, the integrin binding dynamics, highlights the tuneability ofmechanotrans-
duction and its ability to trigger specific outputs in response to both internal and external parameters.Limitations of the Study
Our current results indicate that absence of SHARPIN results in downregulation of integrin a11 protein
levels. We find that integrin a11 localizes slightly more in lysosomes in SHARPIN-deficient than wild-type
cells. This suggests that altered receptor trafficking and increased degradation may contribute partially
to the lower integrin a11 expression. However, additional mechanisms, such as altered mRNA translation,
may also be involved. Therefore, more follow-on studies are necessary to fully unravel the mechanism of
how SHARPIN regulates integrin a11 levels.METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2020.100907.10 iScience 23, 100907, March 27, 2020
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Figure S1. Related to Figure 1. (A) Measurement of total integrin β1 (clone, HMβ1-1) and active integrin 
β1 (clone, 9EG7) cell-surface levels (n=7 independent experiments) in Sharpincpdm relative to wild-type 
MSFs by flow cytometry. (B) Analysis of ECM ligand coating saturation on 2 kPa hydrogels. 2 kPa PAA 
hydrogels coated with 0.1-50 μg/ml fibronectin (left) or collagen I (right). Data are pooled from two 
independent experiments from 4 different gels, nFN=12, 12, 12, 12, 13 and nColl= 13, 12, 12, 12, 13 fields 
of view (from left to right). (C) Representative images of vinculin-containing FAs (green) in wild-type 
and Sharpincpdm MSFs plated for 3-4 h on 0.8, 2, 4 and 13 kPa collagen I-coated PAA hydrogels, nuclei 
(blue) were co-labelled. (D) Representative output images of FA analysis for individual cells plated on 
2 kPa fibronectin-coated PAA hydrogels (FA, red; cell borders, black). (E, F) Quantification of the 
number of FA per cell (E) and the length of FA (F) in wild-type compared to Sharpincpdm MSFs plated 
on fibronectin-coated 0.8, 2, 4 and 13 kPa PAA hydrogels. Data are pooled from three independent 
experiments, nwt= 89, 95, 103, 99 and nSharpincpdm= 66, 79, 82, 82 cells (# FA per cell, from left to right) 
and nwt= 89, 95, 103, 99 and nSharpincpdm= 66, 78, 82, 82 cells (Adhesion length, from left to right). (G) 
Representative images of YAP immunolabeling in wild-type and Sharpincpdm MSFs plated on collagen 
I-coated 2 kPa PAA hydrogels and (H) quantification of nuclear to cytoplasmic localization ratio of YAP.  
Data are pooled from three independent experiments, nwt=156 and nSharpincpdm=240 cells. Mean ± SEM 
in all graphs. Mann–Whitney U-test, red and black lines below p-values indicate the data points 
compared. Scale bars: 20 µm (C,D) and 50 µm (G) .  
 
 
Figure S2. Related to Figure 3. (A) Representative Western blot analysis of pMLC2 and GAPDH protein 
expression in wild-type and Sharpincpdm MSFs or in Talin1-/- MEFs plated on PAA hydrogels with the 
indicated stiffness. (B) Representative Western blot analysis of pMLC2 and GAPDH protein expression 
in control and Sharpincpdm MSFs plated on PAA hydrogels with the indicated stiffness. (C) Relative 
forces exerted by wild-type compared to Sharpincpdm MSFs on collagen I-coated PAA hydrogels with 
the indicated stiffness measured by traction force microscopy. Forces were normalized to the average 
forces exerted by wild-type cells on 0.7 kPa hydrogels in each independent experiment nwt=51, 20, 44, 
24, 42 cells and nSharpincpdm=42, 28, 40, 30, 48 cells (from left to right) from 2-4 independent experiments. 
(D) Representative images of Lifeact-GFP transfected wild-type and Sharpincpdm MSFs or Talin1-/- 
MEFs plated for 2-3 h on 2 kPa collagen-coated PAA hydrogels. Insets are kymographs showing actin 
retrograde flow along the red line (time=125 s, imaged every second). The slope of the line was used 
to calculate the actin retrograde flow rate. (E) Measurement of cell-surface expression of integrin β1, 
active integrin β1, integrin α1, α5 and α11 in Talin1-/- MEFs and wild-type MSFs, (normalized to 
secondary control staining), n=4 independent experiments. (F) Representative images of Talin1-/- 
MEFs and wild-type MSFs plated for 3-4 h on 2 kPa collagen I-coated PAA hydrogels and labelled for 
F-actin (white, upper panel) or vinculin (green, lower panel), nuclei (blue) was co-labelled.  Mean ± SEM 
in all graphs. Mann–Whitney U-test. Red and black lines below p-values indicate the data points 
compared. Scale bars: 20 µm.  
 
Figure S3. Related to Figures 4 and 5. (A) Heat map of integrin mRNA expression in wild-type and 
Sharpincpdm MSFs detected by RNA sequencing (Peuhu et al., 2017). The normalized number of mRNA 
reads from three independent cell isolation replicates is shown. Color scale represents a range from 
0−100 reads. (B) Western blot analysis of integrin α11 and GAPDH protein expression in wild-type and 
Sharpincpdm MSFs plated in full medium on collagen I-coated 2 kPa PAA hydrogel or plastic directly after 
isolation from the mouse mammary gland. (C) Quantification of the relative integrin α11 expression 
levels detected by Western blot analysis of integrin α11 protein expression in wild-type and Sharpincpdm 
MSFs cultured without serum and plated on collagen I., nwt and Sharpincpdm=8 samples from 4 independent 
experiments. GAPDH was detected for loading control. Mann–Whitney U-test, Mean ± SEM shown. (D) 
Validation of Itga1 (upper panel) and Itga11 (lower panel) silencing with siRNA by qPCR (expression 
normalized to GAPDH housekeeping gene), n=1 experiment. 
  
Table S1. Related to Figure 3. 
 
Parameter meaning Value Origin 
Ncl 
Number of FN 
molecules 2000 Adjusted 





Adjusted, of the order of values reported for 
αIIBβ3 (Litvinov et al., 2012) 
nm 
Number of myosin 
motors 
From 2000 





Myosin motor stall 
force 2 pN 
(Molloy et al., 1995)  
vu 
Unloaded myosin 
motor velocity 110 nm/s 




on the membrane 1600 /μm




factor applied to 
force curve 




Adjusted, catch bond dependency form (Elosegui-
Artola et al., 2016; Kong et al., 2009) 
kc 
Clutch spring 
constant 1 nN/nm (Roca-Cusachs et al., 2012) 
ra 
Radius of 





The C57BL/KaLawRij-Sharpincpdm/RijSunJ mouse strain (Stock No: 007599) with a spontaneous 
chronic proliferative dermatitis (cpdm) mutation in Sharpin gene leading to the complete loss of 
SHARPIN protein (HogenEsch et al., 1993; Seymour et al., 2007) was acquired from The Jackson 
Laboratory (Bar Harbor, ME). The colony was maintained and genotyped as previously described 
(Peuhu et al., 2017). Six to seven week-old, female Sharpincpdm (Sharpincpdm/cdpm) mice and littermate 
wild-type mice (Sharpin+/+ or Sharpin+/cpdm) were used for MSFs isolation. Mice were housed in standard 
conditions (12-h light/dark cycle) with food and water available ad libitum. The viability, clinical signs 
and behaviour of the mice were monitored daily. For euthanasia, cervical dislocation was used in 
conjunction with CO2. All animal experiments were ethically assessed and authorised by the National 
Animal Experiment Board and in accordance with The Finnish Act on Animal Experimentation (Animal 
licence number ESAVI-9339-04.10.07-2016)  
Isolation of primary cells 
Isolation of MSFs was performed as previously described (Peuhu et al., 2017). Briefly, mouse mammary 
glands were dissected after sacrifice, lymph nodes removed and the tissue moved to ice cold PBS. The 
tissue was first mechanically disrupted by mincing with scalpel followed by 2-3 h enzymatic digestion 
(1% L-glutamine, insulin 5 µg/ml, gentamycin 50 µg/ml, 5% FCS and 2 mg/ml collagenase in DMEM/F-
12), and DNAse I treatment (20 U/ml). Fibroblasts were isolated by repeated pulse centrifugation (1500 
rpm) and collecting each time the supernatant that contained the stromal cells. After the last pulse 
centrifugation, the collected supernatant was pelleted and resuspended in growth medium (1% L-
glutamine, 1% penicillin/streptomycin, 5% FCS in DMEM/F-12) and the cells plated for culture. Medium 
was replaced the next day to remove non-adherent and dead cells. Throughout the study, cells were 
grown for a maximum of 5 passages before being discarded and experiments were performed on 
multiple cell isolations each of which originated from 2-4 animals. 
Cell culture 
The talin1-/- MEF cell line was described previously (Elosegui-Artola et al., 2016) and was cultured in 
DMEM containing 15 % FCS.  
Transient transfection and gene silencing 
Plasmids [mEmerald-Lifeact-7 (Addgene, #54148) and hITGA11-GFP (pBJ1 human integrin alpha 11-
EGFP; Erusappan, P., et al. Integrin α11 cytoplasmic tail is required for FAK activation to initiate 3D cell 
invasion and ERK-mediated cell proliferation.  Manuscript in preparation)] were transfected using DNA-
In reagent (GST-2131, MTI Global Stem) or Lipofectamine 3000 (L3000075, ThermoFisher) according 
to the manufacturer’s instructions. Briefly a transfection mixture of DNA-In reagent and plasmid was 
prepared in 1:3 ratio (µg DNA: µl DNA:In) in 250 µl Optimem and incubated for 15 min before 
transfection. The transfection mixture was added to adhered cells grown on a 6-well plate in 2.5 ml 
fresh media and cells incubated for 24 h. For transfection with Lipofectamine 3000 reagent a mixture of 
ratio 4:4:2.5 (µl Lipofectamine 3000 reagent: µl P3000TM Enhancer reagent: µg DNA) was prepared in 
500 µl Optimem and incubated for 15 minutes before adding to adhered cells grown on a 6-well plate 
in 2 ml fresh antibiotic free media and cells incubated for 24 h. 
ON-TARGETplus Mouse Itga1 (109700; 5’-CUUUAAUGACGUCGUGAUU-3’, 5´-
GCCUAUGACUGGAACGGAA-3’, 5´-CCACAAUUGACAUCGACAA-3’, and5’-
AGGGCAAGGUGUACGUGUA-3’) and Mouse Itga11 (319480; 5’-AUGGAUGAGAGGCGGUAUA-3´, 
5’-UCAGAAGACAGGAGACGUA-3’, 5’-GCAUCGAGUGUGUGAACGA-3’, and 5’-
CCAGCGACCCUGACGACAA-3’) siRNA –SMARTpools were ordered from Dharmacon, and 
SHARPIN siRNA (5′‐GCUAGUAAUUAAAGACACAd(TT)‐3′) and the scramble Allstars negative control 
siRNA were ordered from QIAGEN. Gene silencing was performed using siRNA oligonucleotides and 
Lipofectamine RNAiMax reagent (13778150, Thermo Fisher Scientific) according to the manufacturer’s 
protocol. Briefly a mixture in 4:3 ratio (µl RNAiMax: µl siRNA) was prepared in 200 µl Optimem and 
incubated for 20 min before adding to adhered cells grown on a 12-well plate in 400 µl fresh media and 
cells incubated for 48 h.  
Preparation of polyacryl-amide hydrogels 
35 mm glass bottom dishes with 14 mm bottom wells (Cellvis, catalog number D35-14-1-N) were treated 
with 1 ml Bind Silane solution (7.14% Plus One Bind Silane (Sigma, GE17-1330-01), 7.14% acetic acid 
in 96 % ethanol) for 30 min, washed twice with 96 % ethanol and left to dry completely. A hydrogel 
mixture containing 7.5-18 % acrylamide solution (Sigma, catalog number A4058) and 0.06-0.4 % bis 
acrylamide solution (Sigma, catalog number M1533), diluted in PBS up to a final volume of 500 µl was 
prepared to obtain hydrogels ranging in stiffness from 0.75-13 kPa. The polymerization of the mixture 
was initialized by adding 5 µl 10 % ammonium persulfate (BioRad, catalog number 1610700) and 1 µl 
N,N,N′,N′-Tetramethylethylenediamine (Sigma, catalog number T9281). The hydrogel solution was 
quickly vortexed, 11.7 µl was added on top of the glass bottom dish, and a 13 mm glass coverslip 
carefully placed on top of the drop and the gel was let to polymerize for 1 h RT incubation. After 
polymerization, the coverslip was carefully removed and the gel incubated with PBS to prevent drying. 
The stiffness of the hydrogels was confirmed by atomic force microscopy as previously described 
(Närvä et al., 2017). 
Gel surface activation and coating 
Gels were incubated for 30 min on slow agitation with 500 µl Sulfo-SANPAH activation solution [0.2 
mg/ml Sulfo-SANPAH (Sigma, catalog number 803332), 2 mg/ml N-(3-Dimethylaminopropyl)-N′-
ethylcarbodiimide hydrochloride (Sigma, catalog number 03450) in 50 mM Hepes] followed by 10 min 
UV-light activation. After the activation gels were washed three times with PBS and coated with either 
fibronectin (Merck-Millipore, catalog number 341631) (20 µg/ml) or collagen type I (Merck-Millipore, 
catalog number 08-115) (20 μg/ml). 
Analysis of ECM ligand coating saturation 
To determine the saturating concentration of the ECM coating, we analysed collagen I and fibronectin 
density on Sulfo-SANPAH -activated 2 kPa hydrogels coated with fibronectin or collagen I at a range of 
concentrations (0.1-50 µg/ml). Activated and coated gels were blocked with 5 % bovine serum albumin 
(Sigma, catalog number A3294) and then incubated with the primary antibodies anti-fibronectin (Sigma, 
catalog number F3648) or anti-Collagen I (Novus Biologicals, catalog number NB600-408) followed by 
incubation with the secondary antibody Alexa fluor 568 anti-rabbit (Thermo Fisher, catalog number 
A10042). Intensity of the antibody staining was imaged by confocal microscopy, and the relative 
fluorescence intensity was calculated after the subtraction of background fluorescence from non-ligand 
coated samples.  
Immunofluorescence 
Cells were fixed and permeabilized with 0.1 % Triton X-100 in 4 % PFA for 8 minutes followed by 10 
min fixation with 4 % PFA. When Bafilomycin A1 was used, cells were treated with 100 nM Bafilomycin 
A1 (Merck-Millipore, catalog number 196000) solubilized in DMSO for 6h prior to fixation. For antibody 
staining against integrin α11 samples were fixed with methanol for 10 min -20 ℃, followed by 10 min 
0.1 % Triton X-100 permeabilization in RT. To block unspecific binding of antibodies cells were 
incubated in 10 % horse serum (HRS) for 1 h in RT. Primary and secondary antibodies were diluted in 
10 % HRS and incubated for 1h in RT. Primary antibodies used: mouse (ms) anti-vinculin (V9131, 
Sigma-Aldrich, 1:500), rat anti-LAMP1 ([1D4B], ab25245, Abcam, 1:100), ms anti-YAP (sc-101199, 
Santa Cruz, 1:100), rabbit (rbt) anti-mouse integrin α11 (provided by Donald Gullberg, 1:200) and rat 
anti-integrin β1, clone MB1.2 (LV1766450, Millipore, 1:100). Secondary antibodies used: Alexa Fluor 
488 anti-mouse (A-21202, Thermo Fisher, 1:400), Alexa Fluor 488 anti-rabbit (A-21206, Thermo Fisher, 
1:400), Alexa Fluor 647 anti-rat (A-21247, Thermo Fisher 1:400) and Alexa Fluor 594 anti-rat (A21209, 
Thermo Fisher 1:400). F-actin was stained with Phalloidin–Atto 647N (65906, Sigma, 1:400), incubated 
together with secondary antibodies and nuclei with DAPI (D1306, Life Technologies 1:3000) for 10 min 
RT after secondary antibody incubation.  
Quantification of immunofluorescence imaging 
Quantification of the cell area and the number, average size, and average length (Feret diameter i.e. 
the longest distance between any two points along the object boundary, also known as maximum 
caliper) of adhesions per cell was based on vinculin immunofluorescence labeling. Quantification of the 
nuclear:cytoplasmic ratio of YAP was performed with CellProfiler from maximum intensity projection 
(MIP) images. Nuclei were segmented based on the DAPI staining, mean intensity was quantified for 
the nuclei and the surrounding cytoplasms. Quantification of the co-localization of integrin α11 and 
Lamp1 was performed with the ImageJ plugin ComDet, https://github.com/ekatrukha/ComDet (Fréal et 
al., 2019), which ignores inhomogeneous cytoplasmic background. We detected integrin α11 spots 
(pixel size 4) that colocalized with Lamp1 spots based on the distance between them (pixel distance 3). 
Then the percentage of integrin α11 spots that co-localized with Lamp1 spots was calculated as the 
number of colocalizing integrin α11 spots of the total number of integrin α11 spots. 
Confocal imaging 
Samples were imaged using 3i (Intelligent Imaging Innovations, 3i Inc) Marianas Spinning disk confocal 
microscope with a Yokogawa CSU‐W1 scanner and Hamamatsu sCMOS Orca Flash 4.0 camera 
(Hamamatsu Photonics K.K.) using 40x/1.1 water objective), LSM 880 Airyscan laser-scanning confocal 
microscope (Zeiss) using 20x/0.8 objective, 63x/ 1.4 oil objective or LSM 880 Airyscan LD LCI confocal 
microscope (Zeiss) using Plan-Apochromat 40x/1.2 water objective and Airyscan detector. 
Flow cytometry 
MSFs were analysed by flow cytometry as previously described (Peuhu et al., 2017). Briefly, cells were 
detached, placed on ice, fixed with 4% PFA in PBS (10 min RT) and resuspended in PBS. Cell surface 
integrins were labelled with fluorochrome-conjugated antibodies [Alexa Fluor 488 anti-integrin β1 
(Clone: HMβ1-1, Biolegend), APC anti-integrin α1 (Clone: HMα1, Biolegend), or Alexa Fluor 488 anti-
integrin α5 (Clone: 5H10-27, Biolegend)] diluted in 100 μL Tyrode’s buffer (10 mM HEPES-NaOH at pH 
7.5, 137 mM NaCl, 2.68 mM KCl, 1.7 mM MgCl2, 11.9 mM NaHCO3, 5 mM glucose, 0.1% BSA)  
according to manufacturer’s instructions for 30 min at RT. Alternatively, cells were first labelled with 
primary antibodies [integrin α11 (AF6498, R&D), or active integrin  β1 (clone 9EG7, BD Pharmingen)] 
followed by secondary antibodies [Alexa Fluor 647 anti-sheep (ab150179, Abcam) or Alexa Fluor 488 
anti-rat (Molecular Probes)] both diluted in Tyrode’s buffer. After washes, the samples were analysed 
using BD LSRFortessa flow cytometer. Live cells were gated from FSC-A/SSC-A dot blot and analysed 
for geometric mean or median fluorescence intensity. The expression of active integrin β1 was 
normalized to the total surface expression of integrin β1. 
Western blotting 
Because of the small hydrogel area (13 mm) on our in-house hydrogels we used the commercial 
hydrogels Softwell® 6, Easy Coat™ (SW6-EC-0.5, SW6-EC-2 EA, SW6-EC-4 EA and SW6-EC-50 EA, 
Matrigen) for immunoblotting samples collected from hydrogels.  
Protein extracts were prepared by lysing the cells with hot TX lysis buffer [50 mM Tris–HCl pH 7.5, 150 
mM NaCl, 5% glycerol, 1% SDS, 0.5% Triton X‐100, Complete protease inhibitor, PhosSTOP (Roche)]. 
Samples were sonicated with BioRuptor and protein concentration was measured by Bio‐Rad to assure 
equal protein loading. The protein extract was first separated by loading equal amounts of protein on 4-
20 % Mini‐PROTEAN® TGX™ Gel SDS–PAGE gradient gels (456-1096, Biorad) and then transferred 
to the nitrocellulose membrane with Trans‐Blot Turbo Transfer Pack (170-4159, Biorad). The membrane 
was blocked for 1 h in RT with 5% milk in Tris Buffered Saline and 0.1% Tween 20 (TBST) solution 
before antibody incubation. Primary and secondary antibodies were incubated for a minimum of 1 h. 
Membranes were scanned and results analyzed with the Odyssey infrared system (LICOR 
Biosciences). Primary antibodies used for western blotting: Rabbit anti-Phospho-Myosin Light Chain 2 
(Thr18/Ser19) (3674, Cell Signaling Technology), rabbit anti-Myosin Light Chain 2 (3672, Cell Signaling 
Technology), mouse anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (5G4-MAb: 6C5, 
HyTest), rabbit anti-SHARPIN (14626-1-AP, Proteintech) and rabbit anti-Integrin α11 (provided by D. 
Gullberg). Secondary antibodies used for western blotting: IRDye® 800CW Donkey anti-Mouse IgG, 
IRDye® 800CW Donkey anti-Rabbit IgG,  IRDye® 680LT Donkey anti-Mouse IgG and IRDye® 680LT 
Donkey anti-Rabbit IgG, diluted 1:10000 in odyssey blocking buffer (LI-COR). Protein levels were 
determined by comparing the signal intensity value of the protein of interest relative to the signal 
intensity value of the corresponding loading control. The relative intensity value was then divided by the 
sum of the relative intensity values in each independent experiment.   
Actin flow 
EGFP-Lifeact transfected cells were plated on 2 kPa collagen coated hydrogels and allowed to spread 
for 45-105 min before image acquisition. Imaging was performed with a Carl Zeiss LSM 880 Airyscan 
microscope using a 63x/1.4 oil immersion objective and its Airyscan detector array. Images were 
acquired every second for 125 seconds and actin flow was measured based on the slope from one 
kymograph per cell drawn along actin fibers close to the cell periphery at the leading edge.  
Traction force microscopy 
For traction force microscopy experiments, cells were seeded 4 h before performing experiments on 
polyacrylamide hydrogels of different stiffness prepared as previously described (Elosegui-Artola et al., 
2016). In addition, new mixtures for hydrogels surrounding the 2 kPa stiffness were prepared (and the 
correct rigidity was verified using AFM): 4 % acrylamide (AA) and 0.03 % bis-acrylamide (bis-AA) used 
for 0. 7 kPa, 5 % AA and 0.04 % bis-AA for 1.6 kPa, 5.5 % AA and 0.044 % bis-AA for 2.5 kPa, 6.2 % 
AA and 0.044 % bis-AA for 2.8 kPa and 7.5 % AA and 0.044 % bis-AA for 5 kPa. Then, simultaneous 
images were acquired of single cells (phase contrast) and of fluorescent 200 nm beads embedded in 
gels. Images were acquired with a Nikon Ti Epifluorescence microscope with a 40x objective (N.A. 0.6). 
Afterwards, cells were trypsinized, and images of bead positions in the gel in the relaxed state were 
acquired. By comparing bead positions in the deformed versus relaxed positions, a map of gel 
displacement caused by cells was measured using a custom particle-imaging-velocimetry software 
(Bazellières et al., 2015). Then, assuming that the displacements were caused by forces exerted by 
cells on the cell-gel contact area, forces were measured using a previously described Fourier transform 
algorithm (Butler et al., 2002; Oria et al., 2017). The average forces per unit area of each cell was then 
measured. 
Magnetic tweezers and bead recruitment experiments 
Magnetic tweezer experiments were performed as previously described (Elosegui-Artola et al., 2014; 
González-Tarragó et al., 2017; Roca-Cusachs et al., 2009). Briefly, 3 µm carboxylated magnetic beads 
(Invitrogen) were coated with a mixture of biotinylated BSA and either biotinylated fibronectin or collagen 
I fragment (10:1 ratio). This fragment was pentameric FN7-10 for fibronectin (Coussen et al., 2002) and 
the GFOGER peptide for collagen I (Emsley et al., 2000). Two hours after seeding cells on glass 
coverslips, coated magnetic beads were deposited on top of the coverslips and allowed to attach to 
cells. Then, magnetic beads on the lamellipodia of single cells were pulled with a 1 nN pulsatory force 
(1 Hz), and the time required to detach beads was measured. To quantify the recruitment of integrin β1, 
3 µm carboxylated silica beads (Kisker Biotech) were used and coated as described above. Instead of 
pulling the beads, cells with silica beads were fixed and stained for integrin β1 (Abcam, 12G10). The 
average intensity of both beads and surrounding areas was quantified, and the difference between 
those values was taken as the integrin recruitment measure. 
Mathematical modelling 
Modelling was carried out using the molecular clutch model previously described in detail (Elosegui-
Artola et al., 2014). Briefly, the model considers a given number of myosin motors, pulling on an actin 
bundle. The actin bundle can bind to a set of collagen ligands through molecular clutches that represent 
adaptor proteins and integrins. In turn, collagen ligands are connected to the substrate through a spring 
constant representing substrate stiffness. Molecular clutches bind to the collagen ligands with an 
effective binding rate, and unbind with an unbinding rate that depends on force as a catch bond. The 
clutches transmit forces to the substrate only when they are bound, and therefore overall force 
transmission critically depends on binding dynamics. In simulations, all parameters remain constant 
except the substrate spring constant (which increases with stiffness), and the number of myosin motors 
pulling on actin, which increases with stiffness following the results in Figure 4D, E. This increase is the 
same for both wild-type and Sharpincpdm cells. The only parameters that are different in the model 
between both conditions (wild-type and Sharpincpdm) are the unbinding and binding rates, which 
increase by the same proportion (8-fold) in Sharpincpdm cells. We note that in contrast to our previous 
work (Elosegui-Artola et al., 2014; Elosegui-Artola et al., 2016; Oria et al., 2017), in this case we do not 
introduce reinforcement in the model, i.e. force-dependent recruitment of additional integrins. This is 
because focal adhesion size and distribution is largely independent of both stiffness and SHARPIN-
deficiency. We also note that for unbinding rate, we took the catch bond force dependence reported in 
(Kong et al., 2009) for α5β1 integrins. This dependency is likely to change for collagen-binding integrins, 
for which unfortunately there are to our knowledge no reported measurements of systematic force-
lifetime measurements at the single molecule level. However, whereas specific levels of force depend 
on this dependence, overall trends with stiffness, and the relative differences if overall unbinding rates 
are altered (as occurs upon SHARPIN depletion) are maintained regardless of the specific force 
dependence assumed. See Table S1 for a list of parameters.   
 
Statistical analysis 
GraphPad software was used for all statistical analyses. Student's t‐test (unpaired, two‐tailed) was used 
when normality could be confirmed by D'Agostino & Pearson omnibus normality test. Nonparametric 
Mann–Whitney U‐test was used when two non‐normally distributed groups were compared or when 
normality could not be tested [due to a too small data set (n < 8)]. Wilcoxon matched‐pairs signed rank 
test was used if samples with unequal variance were compared. Fisher’s exact test was used for the 
analysis of contingency tables. Data are presented in column graphs with mean ± standard error of 
mean (SEM) and P‐values. Individual data points per condition are shown when n ≤ 15, and n‐numbers 
are indicated in figure legends. 
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